EP0781094B1 - Lutte contre les poux de poisson - Google Patents

Lutte contre les poux de poisson Download PDF

Info

Publication number
EP0781094B1
EP0781094B1 EP95931304A EP95931304A EP0781094B1 EP 0781094 B1 EP0781094 B1 EP 0781094B1 EP 95931304 A EP95931304 A EP 95931304A EP 95931304 A EP95931304 A EP 95931304A EP 0781094 B1 EP0781094 B1 EP 0781094B1
Authority
EP
European Patent Office
Prior art keywords
lice
fish
cypermethrin
chalimus
adult
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
EP95931304A
Other languages
German (de)
English (en)
Other versions
EP0781094A2 (fr
Inventor
Julian Charles Braidwood
Jayne Laura Hart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vericore Ltd
Original Assignee
Grampian Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10761189&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EP0781094(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Grampian Pharmaceuticals Ltd filed Critical Grampian Pharmaceuticals Ltd
Priority to EP98117715A priority Critical patent/EP0894434A3/fr
Publication of EP0781094A2 publication Critical patent/EP0781094A2/fr
Application granted granted Critical
Publication of EP0781094B1 publication Critical patent/EP0781094B1/fr
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N53/00—Biocides, pest repellants or attractants, or plant growth regulators containing cyclopropane carboxylic acids or derivatives thereof

Definitions

  • This invention relates to the control of sea lice in fish, such as salmon.
  • a number of treatments have been used to control sea lice in the past, most notably dichlorvos, azamethiphos and hydrogen peroxide treatment baths.
  • a common feature of these known treatments is that they are effective only against mature lice (i.e. lice in the pre-adult and adult phases), and are ineffective against lice in immature phases of development.
  • Hydrogen peroxide has been suggested by some workers to have a limited effect against immature lice, but this effect is slight compared to its effect on mature lice.
  • Resmethrin (but not lambda cyhalothrin) was evaluated for efficacy against immature sea lice, but the document concludes (page 286, lines 9 and 10) that "neither of the formulations of resmethrin appeared to be significantly toxic to larval stages at concentrations which were found to effectively kill adults and pre-adults.”
  • the present invention provides the use of a pyrethroid compound selected from cypermethrin, high-cis-cypermethrin, lambda cyhalothrin and deltamethrin for the manufacture of a composition for the treatment of the chalimus and copepodid phases of sea lice infestation of fish.
  • the invention provides the use of a pyrethroid compound selected from cypermethrin, high-ciscypermethrin, lambda cyhalothrin and deltamethrin for the manufacture of a composition for the prophylaxis of pre-adult and adult sea lice infestation of fish.
  • Trial 1 was carried out at the Marine Harvest International research establishment at Loch Eil, Invernessshire.
  • the fish used in the trial were mixed sex Atlantic Salmon ( Salmo salar ), of the "Marine Harvest M6" strain, aged approximately 28 months, and weighing approximately 3kg each.
  • Each group of fish was placed in an individual experimental sea cage measuring 5m x 5m x 4m (depth) and constructed of nylon mesh nets. The cages were anchored in Loch Eil and open to the sea. Three of the groups were designated as treatment groups and three as control groups.
  • the treatment groups were each subjected to treatment with Cypermethrin at a concentration of 100 ⁇ g/l for one hour.
  • the bottoms of the cages were raised to give cage water depths of 2 metres.
  • Impervious tarpaulins were used to surround individually each of the cages, and oxygen was diffused into the cages using a circular diffusor, to maintain an oxygen level of at least 8mg/l during the time of treatment.
  • Treatment was carried out by measuring an amount of 2.54 wt% stock solution of Cypermethrin calculated to give a final concentration in the cage of 100 ⁇ g/l, mixing this in a bucket of sea water, and then pouring this concentrated mixture into the appropriate cage, at several sites around the cage. After addition of treatment solution to the cages, the tarpaulins remained in place for 1 hour.
  • Trial 2 was carried out at the Marine Harvest International Experimental Challenge Unit at Lochailort, Inverness-shire. Two studies were conducted; firstly, a pilot study (control) in which the rate of survival and development of sea lice on fish in a tank environment was investigated; and secondly a trial study to investigate the effect of Cypermethrin.
  • Treatment of the fish in trial study GP2 was for one hour with trial solution GPRDO1 containing Cypermethrin at a final concentration of 5 ⁇ g/l of seawater.
  • Tables 2B and 2C below indicate the percentages of total sea lice observed in each developmental phase, the results being represented graphically in Fig. 2B.
  • Pilot Study GP1 sea lice development (untreated) Lice Stage 10 days post infestation 21 days post infestation 27 days post infestation Copeopodids 21% Chalimus I 79% Chalimus II 13% Chalimus III 53% Chalimus IV 19% 7% PreAdult 1 15% 46% PreAdult 2 46%
  • Trial Study GP2 seal lice development created with GPRD01 10 days after infestation Lice Stage 10 days post infestation 20 days post infestation 28 days post infestation Copeopodids 6% Chalimus I 92% 12% Chalimus II 2% 54% Chalimus III 32% 12% Chalimus IV 2% 16% PreAdult 1 59% PreAdult 2 13% Adult
  • Trial 3 was carried out at a seawater site in the Faroe Islands, using hexagonal "Bridgestone” cages having a circumference of approximately 102m and a depth in the order of 10 to 12.5m.
  • Cage B was then treated with 700 litres of seawater as a negative control treatment to assess the effect, if any, of the experimental conditions of the fish.
  • the tarpaulin was removed after 60 minutes.
  • the culled fish were counted for Lepeophtheirus salmonis sea lice in the following stages of development: Chalimus I-II, Chalimus III-IV, pre-adult, adult, and gravid female. The numbers of Caligus elongatus sea lice were also counted.
  • the lice counts were logarithmically transformed and analysed using parametric statistical methods.
  • the pre-treatment counts before and after the negative control were analysed by using a two-sample t-test.
  • the negative control did not have a significant effect on the lice numbers of any of the life stages of Lepeoptheirus salmonis or Caligus elongatus , with the exception of the Chalimus I-II stages, this was in fact a statically significant increase in numbers. This may suggest the fish were being continually re-infected with a new generation of lice. (This possible effect was seen between day 8 and 14 post-treatment).
  • Gravid Female lice were collected from Atlantic Salmon and incubated at 14°C for 5 days until the eggs had hatched and developed through the naupilus stages to copeopodids. Approximately 100 copeopodids were added to each of seven beakers of 500ml seawater. Pyrethroids were added to six beakers at a concentration of 5 ⁇ g pyrethroid / litre. One beaker was used as a control. All the beakers were maintained at 14°C for one hour.
  • the reaction were classified as Good, Moderate, Poor and None with reference to the control.
  • Trial 3 demonstrates that the effect of cypermethrin is still statistically significant, even at concentrations as low as 0.9 ⁇ g/l, and furthermore that it is effective not only against immature phases of Lepeoptheirus salmonis , but also against Caligus elongatus . It is anticipated that Cypermethrin will be effective in concentrations ranging from 0.05 ⁇ g/l to 500 ⁇ g/l, the concentration preferably being in the range 0.5 ⁇ g/l to 100 ⁇ g/l.
  • Trial 4 demonstrates the efficacy of other pyrethroid compounds, in particular lambda-cyhalothrin, high-cis-cypermethrin and deltamethrin.
  • sea lice is a general one, which applies to a number of different species of parasite, both of seawater and fresh water fish. It has been found in the past that effective treatments for one species are generally effective against other species also, and the invention therefore extends to the treatment of immature sea lice in general, regardless of species, and regardless of whether the infestations are of seawater or fresh water fish.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Plant Pathology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Environmental Sciences (AREA)
  • Farming Of Fish And Shellfish (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Claims (6)

  1. Utilisation d'un composé pyréthroïde choisi parmi la cyperméthrine, la cyperméthrine à fort taux de cis, la cyhalothrine lambda et la deltaméthrine pour la fabrication d'une composition pour le traitement des phases chalimus et copédite de l'infestation des poissons par les poux de mer.
  2. Utilisation d'un composé pyréthroïde choisi parmi la cyperméthrine, la cyperméthrine à fort taux de cis, la cyhalothrine lambda et la deltaméthrine pour la fabrication d'une composition pour la prophylaxie de l'infestation des poissons par les poux de mer pré-adultes et adultes.
  3. Utilisation selon la revendication 1 ou la revendication 2, dans laquelle la composition est adaptée à l'administration locale aux poissons.
  4. Utilisation selon la revendication 3, dans laquelle la composition comprend une solution ou une suspension du composé pyréthroïde.
  5. Utilisation selon la revendication 4, dans laquelle la solution ou la suspension contient le composé pyréthroïde à une concentration comprise entre 0,05 µg/l et 500 µg/l.
  6. Utilisation selon la revendication 5, dans laquelle la concentration est comprise entre 0,5 µg/l et 100 µg/l.
EP95931304A 1994-09-12 1995-09-08 Lutte contre les poux de poisson Revoked EP0781094B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP98117715A EP0894434A3 (fr) 1994-09-12 1995-09-08 Lutte contre les poux de poisson

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9418328A GB9418328D0 (en) 1994-09-12 1994-09-12 Control of sea lice in seawater fish
GB9418328 1994-09-12
PCT/GB1995/002153 WO1996008138A2 (fr) 1994-09-12 1995-09-08 Lutte contre les poux de poisson

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP98117715A Division EP0894434A3 (fr) 1994-09-12 1995-09-08 Lutte contre les poux de poisson

Publications (2)

Publication Number Publication Date
EP0781094A2 EP0781094A2 (fr) 1997-07-02
EP0781094B1 true EP0781094B1 (fr) 1999-02-17

Family

ID=10761189

Family Applications (2)

Application Number Title Priority Date Filing Date
EP98117715A Ceased EP0894434A3 (fr) 1994-09-12 1995-09-08 Lutte contre les poux de poisson
EP95931304A Revoked EP0781094B1 (fr) 1994-09-12 1995-09-08 Lutte contre les poux de poisson

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP98117715A Ceased EP0894434A3 (fr) 1994-09-12 1995-09-08 Lutte contre les poux de poisson

Country Status (9)

Country Link
US (1) US5770621A (fr)
EP (2) EP0894434A3 (fr)
AU (1) AU3479295A (fr)
CA (1) CA2199627C (fr)
DK (1) DK174665B1 (fr)
ES (1) ES2129849T3 (fr)
GB (1) GB9418328D0 (fr)
NO (1) NO325019B1 (fr)
WO (1) WO1996008138A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6062170A (en) * 1998-06-01 2000-05-16 Nutreco Canada Inc. Method and apparatus for plankton reduction in fish farming
AU5837900A (en) * 1999-07-23 2001-02-13 Bioparken As Control of crustacean infestation of aquatic animals
GB2371053A (en) * 2001-01-13 2002-07-17 David R Harper Microbiological control of sea lice
WO2002054873A2 (fr) * 2001-01-13 2002-07-18 Biocontrol Ltd Agents de neutralisation
CA2705544A1 (fr) * 2007-11-19 2009-05-28 Calanus As Compositions de copepode bioactives, procedes pour leur production, et utilisation de ces compositions pour prevenir ou traiter des hotes infestes par des ectoparasites similairesau plan phylogenetique
NO20110625A1 (no) * 2011-04-27 2012-08-20 Ocea As Lusebehandlingssystem og tilhørende fremgangsmåte for behandling av lus
GB2500381A (en) * 2012-03-19 2013-09-25 Marine Harvest Scotland Ltd The combination of pyrethroid and hydrogen peroxide for control of ectoparasite infestation in fish
NO338812B1 (no) * 2013-09-27 2016-10-24 Lutra As System for badebehandling av fisk infisert med en ekstern fiskeparasitt og framgangsmåte for bruk av kaliumklorid som behandlingsmiddel i systemet
CN107568112A (zh) * 2017-09-12 2018-01-12 钦州学院 一种通过控制胺菊酯浓度提高可口革囊星虫存活率的方法
US20240116854A1 (en) * 2021-01-27 2024-04-11 Intervet Inc. Cyclopropylamide compounds against parasites in fish
CA3209562A1 (fr) * 2021-01-27 2022-08-04 Intervet International B.V. Composes de cyclopropylamide contre des parasites chez les poissons

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9105694D0 (en) * 1991-03-18 1991-05-01 Hand Peter Animal Health Control of sea lice in salmon

Also Published As

Publication number Publication date
EP0781094A2 (fr) 1997-07-02
WO1996008138A2 (fr) 1996-03-21
EP0894434A2 (fr) 1999-02-03
US5770621A (en) 1998-06-23
DK26097A (da) 1997-05-12
ES2129849T3 (es) 1999-06-16
DK174665B1 (da) 2003-08-18
NO971119L (no) 1997-03-11
AU3479295A (en) 1996-03-29
CA2199627A1 (fr) 1996-03-21
NO325019B1 (no) 2008-01-14
GB9418328D0 (en) 1994-11-02
NO971119D0 (no) 1997-03-11
WO1996008138A3 (fr) 1996-05-30
CA2199627C (fr) 2007-05-08
EP0894434A3 (fr) 1999-03-24

Similar Documents

Publication Publication Date Title
US8293286B2 (en) Natural compositions for killing parasites on a companion animal
Hougard et al. Comparative performances, under laboratory conditions, of seven pyrethroid insecticides used for impregnation of mosquito nets
EP0781094B1 (fr) Lutte contre les poux de poisson
US20040109883A1 (en) Pediculicidal and ovacidal treatment compositions and methods for killing head lice and their eggs
Folz et al. Clinical evaluation of amitraz as a treatment for canine demodicosis
RU2302858C2 (ru) Паразитицидные композиции и способы их применения
EP1083907B1 (fr) Lutte contre les infections parasitaires des poissons d'elevage ou sauvages
Pettis et al. Fluvalinate treatment of queen and worker honey bees (Apis mellifera L) and effects on subsequent mortality, queen acceptance and supersedure
EP0616494B1 (fr) Derives de 1- n-(halo-3-pyridylmethyle)]-n-methylamino-1-alkylamino-2-nitroethylene pour lutter contre les puces chez les animaux domestiques
CA2106295C (fr) Lutte contre les poux de poisson chez les poissons marins
Lorio Experimental control of metacercariae of the yellow grub Clinostomum marginatum in channel catfish
EP1784073A1 (fr) Formulation de méthoprène pour le contrôle des infestations de tics
Davey et al. Efficacy of various concentrations of coumaphos to control adult, nymphal, and larval stages of an organophosphate-resistant strain of Boophilus microplus on infested cattle
Rehbein et al. Efficacy of a new long-acting formulation of ivermectin and other injectable avermectins against induced Psoroptes ovis infestations in cattle
Peleg Effect of a new insect growth regulator, RO 13-5223, on hymenopterous parasites of scale insects
Loomis et al. Comparative effectiveness of fenvalerate and carbaryl sprays against the northern fowl mite
Soll et al. Control of induced infestations of three African multihost tick species with sustained-release ivermectin
Folz et al. Chemotherapeutic treatment of naturally acquired generalized demodicosis
Roth et al. Preliminary studies on the efficacy of two pyrethroid compounds, resmethrin and lambda-cyhalothrin, for the treatment of sea lice (Lepeophtheirus salmonis) infestations of Atlantic salmon (Salmo salar)
Maynard et al. Field efficacy of a 10 per cent pyriproxyfen spot‐on for the prevention of flea infestations on cats
JP2006508957A (ja) 害虫を防除するための組合せ生成物
JP2021526793A (ja) 魚類からの外部寄生虫類の除去処理
Meifert et al. House fly, Musca domestica, control with chemosterilants and insecticides
Hamel A new method of tick control in cattle
WO2010048891A1 (fr) Procédé de prévention et de destruction d'ectoparasites d'animaux endothermes par application combinée d'amitraz et de bifenthrine

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19970310

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): ES FR GB IE SE

17Q First examination report despatched

Effective date: 19971203

EL Fr: translation of claims filed
GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

TPAD Observations filed by third parties

Free format text: ORIGINAL CODE: EPIDOS TIPA

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): ES FR GB IE SE

ET Fr: translation filed
REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

RAP2 Party data changed (patent owner data changed or rights of a patent transferred)

Owner name: VERICORE LIMITED

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2129849

Country of ref document: ES

Kind code of ref document: T3

PLBQ Unpublished change to opponent data

Free format text: ORIGINAL CODE: EPIDOS OPPO

PLBI Opposition filed

Free format text: ORIGINAL CODE: 0009260

PLBQ Unpublished change to opponent data

Free format text: ORIGINAL CODE: EPIDOS OPPO

PLBI Opposition filed

Free format text: ORIGINAL CODE: 0009260

26 Opposition filed

Opponent name: ALPHARMA AS

Effective date: 19991112

PLBF Reply of patent proprietor to notice(s) of opposition

Free format text: ORIGINAL CODE: EPIDOS OBSO

26 Opposition filed

Opponent name: AKZO NOBEL N.V.

Effective date: 19991117

Opponent name: ALPHARMA AS

Effective date: 19991112

PLBF Reply of patent proprietor to notice(s) of opposition

Free format text: ORIGINAL CODE: EPIDOS OBSO

PLBF Reply of patent proprietor to notice(s) of opposition

Free format text: ORIGINAL CODE: EPIDOS OBSO

PLBF Reply of patent proprietor to notice(s) of opposition

Free format text: ORIGINAL CODE: EPIDOS OBSO

PLBF Reply of patent proprietor to notice(s) of opposition

Free format text: ORIGINAL CODE: EPIDOS OBSO

PLBF Reply of patent proprietor to notice(s) of opposition

Free format text: ORIGINAL CODE: EPIDOS OBSO

PLBQ Unpublished change to opponent data

Free format text: ORIGINAL CODE: EPIDOS OPPO

PLAB Opposition data, opponent's data or that of the opponent's representative modified

Free format text: ORIGINAL CODE: 0009299OPPO

REG Reference to a national code

Ref country code: GB

Ref legal event code: IF02

R26 Opposition filed (corrected)

Opponent name: ALPHARMA AS * 19991117 AKZO NOBEL N.V.

Effective date: 19991112

PLBO Opposition rejected

Free format text: ORIGINAL CODE: EPIDOS REJO

APAC Appeal dossier modified

Free format text: ORIGINAL CODE: EPIDOS NOAPO

APAC Appeal dossier modified

Free format text: ORIGINAL CODE: EPIDOS NOAPO

APAC Appeal dossier modified

Free format text: ORIGINAL CODE: EPIDOS NOAPO

APAC Appeal dossier modified

Free format text: ORIGINAL CODE: EPIDOS NOAPO

APAC Appeal dossier modified

Free format text: ORIGINAL CODE: EPIDOS NOAPO

APAA Appeal reference recorded

Free format text: ORIGINAL CODE: EPIDOS REFN

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20050722

Year of fee payment: 11

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SE

Payment date: 20050729

Year of fee payment: 11

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IE

Payment date: 20050803

Year of fee payment: 11

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20050812

Year of fee payment: 11

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20050901

Year of fee payment: 11

APAH Appeal reference modified

Free format text: ORIGINAL CODE: EPIDOSCREFNO

APAH Appeal reference modified

Free format text: ORIGINAL CODE: EPIDOSCREFNO

APBU Appeal procedure closed

Free format text: ORIGINAL CODE: EPIDOSNNOA9O

RDAF Communication despatched that patent is revoked

Free format text: ORIGINAL CODE: EPIDOSNREV1

RDAG Patent revoked

Free format text: ORIGINAL CODE: 0009271

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: PATENT REVOKED

27W Patent revoked

Effective date: 20060404

GBPR Gb: patent revoked under art. 102 of the ep convention designating the uk as contracting state

Free format text: 20060404

REG Reference to a national code

Ref country code: SE

Ref legal event code: ECNC

PLAB Opposition data, opponent's data or that of the opponent's representative modified

Free format text: ORIGINAL CODE: 0009299OPPO